GL1X · GenesisL1 explorer

Ligand · U89

U89 · N-[4-[[3-(2,4-diamino-1,6-dihydro-6-oxo-4-pyrimidinyl)-propyl]-[2-((2-oxo-2-((4-phosphoriboxy)-butyl)-amino)-ethyl)-thio-acetyl]-amino]benzoyl]-1-glutamic acid

U89, N-[4-[[3-(2,4-diamino-1,6-dihydro-6-oxo-4-pyrimidinyl)-propyl]-[2-((2-oxo-2-((4-phosphoriboxy)-butyl)-amino)-ethyl)-thio-acetyl]-amino]benzoyl]-1-glutamic acid (C27 H38 N7 O12 P S, 715.7 g/mol), in the MolNFT structures on GenesisL1…

Component
U89
Formula
C27 H38 N7 O12 P S
Class
ligand
Structures
2
PDB entries
1

Binding sites

U89 in 2 structures; the first of them:

  • 1GAR · Towards structure-based drug design: crystal structure of a multisubstrate adduct complex… · U89 A213 · binds GLY9, ASN10, GLY11, SER12, ASN13, ARG64, ALA86, GLY87 and 19 more
  • 1GAR · Towards structure-based drug design: crystal structure of a multisubstrate adduct complex… · U89 A213 · binds GLY9, ASN10, GLY11, SER12, ASN13, ARG64, ALA86, GLY87 and 19 more

Residues it binds most

GLY 4, ASN 4, LEU 4, ARG 4, HIS 4, ILE 4, VAL 4, GLU 4, ALA 4, ASP 4 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.